NCT04679649

Brief Summary

This protocol is for a pragmatic randomised controlled clinical trial (RCT) with a manual spinal mobilisation (MSM) intervention for patients with axial spondyloarthritis (axSpA), embedded in a Trials within Cohort (TwiCs) design. This trial might appear as a standardised RCT but there is a secondary element - an observational cohort the trial is embedded in. Trial A is the first (of possibly several) embedded pragmatic RCTs involving physiotherapy interventions that may identify therapies that will help improve outcomes for patients with axSpA. The investigators are seeking to improve outcomes for these patients by comparing different physiotherapy interventions in subsequent trials with standard of care (SoC) physiotherapy. Trial A will compare routine care vs routine care plus MSM physiotherapy attempting to answer the primary research question if MSM on patients with axSpA improves spinal mobility. In order to recruit patients and obtain outcomes for Trial A (n=70), the investigators will first recruit up to 300 axSpA patients receiving care at the Royal National Hospital for Rheumatic Diseases (RNHRD) in Bath into a cohort and observe their standard of care outcomes. This will allow to answer the cohort's research question of "How does SoC physiotherapy in patients with axSpA reflect in data collected routinely on outcomes of the disease?" Patients will be asked to consent to provide routine observational data on their wellbeing, be approached to take part in future trials of interventions which aim to improve outcomes for patients with axSpA, and not be approached unless they are offered the physiotherapy trial intervention. This highly pragmatic method of providing information and seeking consent replicates the informed consent procedures in routine care clinical settings. This study is aimed to last three years, with individual trials of 40-70 participants, ranging between three to six months duration of therapy intervention in addition to routine care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 16, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 22, 2020

Completed
10 months until next milestone

Study Start

First participant enrolled

October 6, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2022

Completed
Last Updated

May 16, 2024

Status Verified

April 1, 2024

Enrollment Period

9 months

First QC Date

November 16, 2020

Last Update Submit

May 14, 2024

Conditions

Keywords

physiotherapymanual mobilisationaxial spondyloarthritis

Outcome Measures

Primary Outcomes (2)

  • Change of Spinal Mobility

    Spinal mobility will be measured using inertial measurement unit sensors; Electro muscle stimulation (EMS) for muscle activity

    baseline, 6 months, and follow-up at 12 months

  • Change of Spinal Mobility

    Spinal mobility will be measured using the Bath Ankylosing Spondylitis Metrology Index (BASMI), scored on the mean of 5 items out of 0-10 (minimum value 0 maximum value 10), '0' being the best outcome and 10 being the worst outcome.

    baseline, 3 months & 6 months, and follow-up at 12 months

Secondary Outcomes (5)

  • Change of Disease Activity

    baseline, 3 month, 6 month, 12 month

  • Change of Functional limitation

    baseline, 3 month, 6 month, 12 month

  • Change of Quality of Sleep (PROM)

    baseline, 3 month, 6 month, 12 month

  • Change of Quality of Life (PROM)

    baseline, 3 month, 6 month, 12 month

  • Change of Work Productivity (PROM)

    baseline, 3 month, 6 month, 12 month

Study Arms (2)

Trial A - Intervention Group (manual mobilisation)

EXPERIMENTAL

Participants will continue to receive routine care and 13 sessions of manual spinal mobilisation will be administered over a 6 months period to compare routine care vs routine care plus manual spine mobilisation physiotherapy.

Other: Manual spinal mobilisation physiotherapy

Trial A - Control Group (routine care)

NO INTERVENTION

Participants in control group will continue to receive routine care, and routine care measurements for axial spondyloarthritis will be taken at baseline, 3 months and 6 months plus follow up.

Interventions

Manual spinal mobilisation is a physiotherapy technique to improve spinal mobility by gently applying pressure manually on the each segmental vertebrae by hands-on treatment of a physiotherapist.

Also known as: "Maitland's" mobilisations
Trial A - Intervention Group (manual mobilisation)

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients \> 18 years of age from the RUH Bath National Health Service (NHS) Foundation Trust Rheumatology service based at RNHRD who fulfil the modified New York Criteria or the Assessment of SpondyloArthritis international Society (ASAS) axial spondyloarthritis criteria giving written consent for participation.

You may not qualify if:

  • Mechanical spinal disease causing red flag symptoms such as cauda equina syndrome
  • Age \>70
  • Pregnancy or breastfeeding
  • Any malignancy
  • Moderate coexistent other inflammatory conditions (such as rheumatoid arthritis, vasculitis or connective tissue disease, in order to minimise the effect particularly of inflammation). However clinical judgement might be used to judge the severity in some patients as to whether they are safe to be included in a trial.
  • Any bridging syndesmophytes in the spine, to avoid the risk of causing vertebral fractures or instability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Sports Physiotherapy Calne

Calne, UK, SN11 9PR, United Kingdom

Location

Royal National Hospital for Rheumatic Diseases (RNHRD)

Bath, Wiltshire, BA1 3NG, United Kingdom

Location

MeSH Terms

Conditions

Axial Spondyloarthritis

Condition Hierarchy (Ancestors)

SpondylarthropathiesSpondylarthritisSpondylitisSpinal DiseasesBone DiseasesMusculoskeletal DiseasesAnkylosisJoint DiseasesArthritis

Study Officials

  • Jane Carter

    Royal United Hospitals Bath NHS FT

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Batch randomisation - computer generated
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Pragmatic randomised controlled clinical trial (RCT) with secondary element of observational cohort trial in line with the "Trials within Cohort design" (TwiCs). Trial A is Manual mobilisation of the spine.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 16, 2020

First Posted

December 22, 2020

Study Start

October 6, 2021

Primary Completion

June 20, 2022

Study Completion

July 30, 2022

Last Updated

May 16, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will share

Dr Sengupta has established a national and international panel of collaborators in the field of axial spondyloarthritis. We will therefore try to maintain our links with other experts in the field who are conducting cutting edge research in axSpA. Thus, the data collected as part of this study may be used in further research. Anonymised data may be shared with other researchers investigating non-pharmaceutical therapies in spondyloarthropathy. Requests for data would be evaluated on the basis of the research objectives of the intended project and any conflict of interests involved. If approved, recipients of data must forward copies of their protocol and ethics approval if appropriate to Dr Sengupta and the sponsor (RUH Bath NHS Foundation Trust Rheumatology service based at the RNHRD).

Shared Documents
STUDY PROTOCOL, ICF, CSR
Time Frame
Study Protocol and Consent form become available once recruitment has started. Clinical Study report becomes available on study conclusion.
Access Criteria
request access through Dr Raj Sengupta

Locations